Delivery Order SPE2DB24D1205-SPE2DB25FCYZD
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,611.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,915.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-prescribed anticoagulant medication. Issued on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24.8K on July 18, 2025, for the supply of 60-count bottles of Eliquis 5 mg tablets, a commonly prescribed anticoagulant medication. This non-competitive, firm fixed-price delivery order reflects continued pharmaceutical procurement through the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as the contractor's corporate office in...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency (DLA) awarded a $18,987.24 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce the risk of stroke and blood clots, and this order supports pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,546.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $8,405.86 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was awarded through open...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYZDDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $33,966.52 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. Issued on July 28, 2025, with an ultimate completion date of July 29, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award process with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support for military healthcare systems and related federal agencies, enabling AmerisourceBergen to supply a diverse portfolio of medications, vaccines, medical devices, and specialized healthcare commodities. The arrangement allows the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through a flexible contracting mechanism that supports ongoing military medical supply requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 7/28/25 |